- Societies
- SSMO,
- SSRO
- Categories
- Joint Session
Current practice in urogenital Ca
-
Muscle invasive Bladder cancer (MIBC) – e new era of management The end of Cisplatin-based chemotherapy in 2026 ?
- Presentation time:
- 15 min
- Discussion time:
- 5 min
-
Debate : Radical Cystectomy remains the key corner stone of cure for MIBC 20’
- Presentation time:
- 10 min
- Discussion time:
- 5 min
Speaker: Philippe Sèbe , Thomas Zilli
-
Renal Cell Carcinoma: adjuvant therapy for patients with clear cell RCC at risk of relapse : from Pembrolizumab to combination therapy
- Presentation time:
- 15 min
- Discussion time:
- 5 min
Speaker: Christian Rothermundt
-
Have we arrived at a personalized treatment era in advanced prostate cancer?
- Presentation time:
- 20 min
- Discussion time:
- 5 min
Speaker: Aurelius Omlin